GBA1 and Parkinson disease: Patients carrying severe GBA1 mutations were associated with positive family history of parkinsonism and/or dementia, an earlier onset of disease, more profound cognitive decline, a higher prevalence of RBD, and decreased cerebrospinal fluid (CSF) levels of total α‐synuclein (Lerche et al., 2020).